Ratings Summary for LUNESTA
Overall Patient opinion of LUNESTA: 2.7 (somewhat satisfied)
(based on 851 reviews ) (updated May 6, 2025)Ratings by Age Group for LUNESTA
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 8 | 3.7 |
| Age 18 to 24 | 64 | 2.6 |
| Age 25 to 34 | 175 | 2.6 |
| Age 35 to 44 | 233 | 2.7 |
| Age 45 to 54 | 207 | 2.8 |
| Age 55 to 64 | 107 | 3.0 |
| Age 65 to 74 | 35 | 2.7 |
| Age 75 and up | 7 | 1.8 |
Ratings by Sex for LUNESTA
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 277 | 2.89530685920578 |
| Female | 567 | 2.73721340388007 |
| Not Specified | 7 | 2.57142857142857 |
Would you like to find reviews for LUNESTA taken for a specific reason or resulting in a specific side effect?
Filter Results for LUNESTA
FDA Drug Safety Information for LUNESTA
Check here for Ask a Patient's Adverse Event Summary for LUNESTA based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
LUNESTA (ESZOPICLONE): This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Eszopiclone belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment. FDA Approval Date: 2004-12-15 (Sources: U.S. Centers for Medicare Services, FDA)
